Christopher J Clarke

8PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersCell development, proliferation and deathGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 25, 2026
Neutral Sphingomyelinase-2 Restrains TAZ to Suppress Breast Tumor Growth.

|Feb 23, 2026
Metabolic plasticity of sphingolipids governs cancer cell fitness in acidic tumor ecosystems.

Raafat Chalar, Naheel Khatri, Jowana Obeid

|Apr 01, 2025
A Critical Role for Neutral Sphingomyelinase-2 in Doxorubicin-induced Cardiotoxicity.

Samia Mohammed, Victoria Alvarado, Ya-Ping Jiang

|Jan 20, 2025
Serum and Plasma Sphingolipids as Biomarkers of Anthracycline-Induced Cardiotoxicity.

Samia Mohammed, Andreas P Kalogeropoulos, Victoria Alvarado

|Dec 16, 2024
Remote organ cancer induces kidney injury, inflammation, and fibrosis and adversely alters renal function.

Dana Hammouri, Andrew Orwick, Mark A Doll

|Apr 07, 2022
Ca2+-activated sphingomyelin scrambling and turnover mediate ESCRT-independent lysosomal repair.

Patrick Niekamp, Felix Scharte, Tolulope Sokoya

Pageof 2